Plasma Collection Continues to Gain Traction in Czech Republic

Informations

• Publié par: plasma-protein-therapeutics-association-ppta
• Nombre de lectures: 11
• Langue: English

Extrait

Plasma Collection Continues to Gain Traction in Czech Republic

PR Newswire ANNAPOLIS, Maryland, Nov. 13, 2012

-- UNICAplasma Achieves International Certification, Donating Plasma Website Launched

ANNAPOLIS, Maryland,Nov. 13, 2012/PRNewswire/ -- ThePlasma Protein Therapeutics Association(PPTA) has awardedUNICAplasma, s. r. o.withInternational Quality Plasma Program(IQPP) certification for its plasma collection center in Prague.

Certification is obtained via a rigorous inspection by an independent third party, and demonstrated compliance with voluntary standards that ensure the highest level of quality and safety of human source plasma.

Milan Maly, Owner and CEO ofUNICAplasma, s. r. o. said, "Getting the IQPP certificate is a key step in our pursuit of perfection. It allows us to demonstrate both to our donors and to the relevant authorities how important quality and safety are to us."

People worldwide depend on lifesaving plasma protein therapies to treat bleeding and immune disorders, other diseases and injury. Since 2009, UNICAplasma's mission has been to save lives through safe and efficient collection of human blood plasma for the manufacture of plasma protein therapies.

Joshua Penrod, Vice President, PPTA Source said, "W e congratulate UNICAplasma, s.r.o., on obtaining this mark of distinction which demonstrates their commitment to plasma quality and safety."

This news comes on the heels of the first IQPP certification earlier this year. In recognition of the growing importance of plasma collection and the demand for human source plasma, PPTA has launched a website www.darovaniplazmy.czthat contains a wealth of information for consumers on donor eligibility requirements, safety and quality, plasma protein therapies and more.

About the Plasma Protein Therapeutics Association

ThePlasma Protein Therapeutics Association(PPTA) is a dynamic trade association that represents a unique sector of the biologics and biotechnology industry. PPTA member companies manufacture high-impact, high-value plasma protein therapies.

PPTA and its members focus on patient access to therapies and work globally with more than patient organizations, policymakers and other stakeholders to ensure that patients who infuse or inject these complex biologics have confidence in their safety and quality.

Additionally, PPTA also administers standards programs, including theInternational Quality Plasma Program(IQPP) andQuality Standards of Excellence, Assurance and Leadership(QSEAL): theNational Donor Deferral Registry(NDDR), and thePatient Notification System(PNS).

AboutUNICAplasma, s. r. o. UNICAplasma's mission is to contribute to saving lives through safe and efficient collection of human blood plasma needed to produce plasma protein therapies. Fulfilling this mission is made possible in cooperation and partnership with plasma donors. UNICAplasma employs a highly qualified workforce, advanced technology and equipment and strict controls to facilitate the highest level of quality and safety for both donors and patients.